The human papillomavirus vaccine can significantly cut recipients’ risk of several types of cancer. So why are vaccination rates relatively low in the U.S.?
by Brad Jones
The multiple tumors in patients with metastatic disease share key genetic traits, a sequencing study shows.
by Anna Azvolinsky
Computational and molecular biologist Sourav Bandyopadhyay discusses new ways to think about chemotherapy.
by Sue Rochman
Why replacing red meat with fish may be just what the doctor ordered.
by Brenda Conaway
Night shift work may contribute to a heightened cancer risk.
by Jane C. Hu
FROM THE EDITOR-IN-CHIEF
CAR-T cells are being rebuilt to kill cancer cells.
by William G. Nelson, MD, PhD
Study findings support precision approaches to risk reduction.
by Dara Chadwick
Scientists are testing treatments on lab-grown tumor tissue.
by Chris Palmer
High-tech goggles to help surgeons remove tumors.
After decades without treatment advances, options for patients with bladder cancer are now more numerous.
by Kendall K. Morgan
A study sheds light on the difficulty patients have in accessing their medical records, and the U.S. Food and Drug Administration expands approval of the human papillomavirus vaccine.
by Kate Yandell
Cancer immunology researchers are awarded a Nobel Prize, and a seventh immune checkpoint inhibitor is approved by the U.S. Food and Drug Administration.
A professional photographer shares advice on living in the moment after caring for his father, who had stage IV lung cancer.
by Jay Perry
A study investigates whether artificial intelligence can reduce false-positive mammograms.
Three new cancer treatments have been approved by the U.S. Food and Drug Administration.
James P. Allison, PhD, a Fellow of the AACR Academy, won the 2018 Nobel Prize in Physiology or Medicine for his pioneering work in cancer immunotherapy.
Janet Freeman-Daily: On Lung Cancer and Blame
donate to the AACR